SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-211264
Filing Date
2013-05-09
Accepted
2013-05-09 16:46:19
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d502940d10q.htm 10-Q 467972
2 EX-31.1 d502940dex311.htm EX-31.1 9362
3 EX-31.2 d502940dex312.htm EX-31.2 9361
4 EX-32.1 d502940dex321.htm EX-32.1 4998
  Complete submission text file 0001193125-13-211264.txt   2848389

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nktr-20130331.xml EX-101.INS 319296
6 XBRL TAXONOMY EXTENSION SCHEMA nktr-20130331.xsd EX-101.SCH 36355
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20130331_cal.xml EX-101.CAL 52846
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20130331_def.xml EX-101.DEF 78334
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20130331_lab.xml EX-101.LAB 258396
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20130331_pre.xml EX-101.PRE 168323
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 13829553
SIC: 2834 Pharmaceutical Preparations